Top Indian Official Hints At Drug Price Regulation To Curb ‘Profiteering’
Executive Summary
A top Indian pharmaceutical department official says the government is determined to press ahead with its push for the prescription of more ‘no-name’ generic drugs in the face of a perception of profiteering by the pharma industry.